MétaCan
Menu
Back to cohort
Record W3004637332 · doi:10.1186/s13058-020-1247-4

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

2020· article· en· W3004637332 on OpenAlexafffund
Nasim Mavaddat, Antonis C. Antoniou, Thea M. Mooij, Maartje J. Hooning, Bernadette A. M. Heemskerk‐Gerritsen, Catherine Noguès, Marion Gauthier‐Villars, Olivier Caron, Paul Gesta, Pascal Pujol, Alain Lortholary, Daniel Barrowdale, Debra Frost, D. Gareth Evans, Louise Izatt, Julian Adlard, Rosalind A. Eeles, Carole Brewer, Marc Tischkowitz, Alex Henderson, Jackie Cook, Diana Eccles, Klaartje van Engelen, Marian J.E. Mourits, Margreet G.E.M. Ausems, Linetta B. Koppert, John L. Hopper, Esther M. John, Wendy K. Chung, Irene L. Andrulis, Mary B. Daly, Saundra S. Buys, Javier Benı́tez, Trinidad Caldés, Anna Jakubowska, Jacques Simard, Christian F. Singer, Yen Y. Tan, Edith Oláh, Marie Navrátilová, Lenka Foretová, Anne‐Marie Gerdes, Marie-José Roos-Blom, Flora E. van Leeuwen, Brita Arver, Håkan Olsson, Rita K. Schmutzler, Christoph Engel, Karin Kast, Kelly‐Anne Phillips, Mary Beth Terry, Roger L. Milne, David E. Goldgar, Matti A. Rookus, Nadine Andrieu, Douglas F. Easton

Bibliographic record

VenueBreast Cancer Research · 2020
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsSinai Health SystemUniversité LavalLunenfeld-Tanenbaum Research InstituteCentre hospitalier universitaire de QuébecUniversity of Toronto
FundersNational Cancer InstituteInstituto de Salud Carlos IIINational Center for Advancing Translational SciencesMedical Research CouncilCentre Léon BérardCentro de Investigación Biomédica en Red de CáncerInstitut Claudius RegaudInstitut Gustave-RoussyMinistero dello Sviluppo EconomicoNational Health and Medical Research CouncilInstitut National Du CancerNewcastle upon Tyne Hospitals NHS Foundation TrustHungarian Scientific Research FundMinisterio de Economía y CompetitividadNederlandse Organisatie voor Wetenschappelijk OnderzoekFondation de FranceGreat Ormond Street Hospital for ChildrenTrinity College DublinCanadian Institutes of Health ResearchCancerfondenNational Breast Cancer FoundationMinisterstvo Školství, Mládeže a TělovýchovyCentral Manchester University Hospitals NHS Foundation TrustUniversity of NottinghamCancer AustraliaUniversity of AberdeenInstitut BergoniéDeutsche KrebshilfeUniversity of GlasgowEuropean CommissionFondation du cancer du sein du QuébecKWF KankerbestrijdingNottingham University Hospitals NHS TrustUniversity of SouthamptonCancer Research UKNorway GrantsNemzeti Kutatási Fejlesztési és Innovációs HivatalGovernment of CanadaLunds UniversitetUniversity Hospitals of Leicester NHS TrustRoyal Marsden NHS Foundation TrustMinistère du Développement Économique, de l’Innovation et de l’ExportationNational Institute for Health and Care ResearchGenome Canada
KeywordsMedicineBreast cancerSurgical oncologyProspective cohort studyOncologyMenopauseGynecologyOophorectomyInternal medicineCancerGeneral surgerySurgeryHysterectomy

Abstract

fetched live from OpenAlex

BACKGROUND: The effect of risk-reducing salpingo-oophorectomy (RRSO) on breast cancer risk for BRCA1 and BRCA2 mutation carriers is uncertain. Retrospective analyses have suggested a protective effect but may be substantially biased. Prospective studies have had limited power, particularly for BRCA2 mutation carriers. Further, previous studies have not considered the effect of RRSO in the context of natural menopause. METHODS: A multi-centre prospective cohort of 2272 BRCA1 and 1605 BRCA2 mutation carriers was followed for a mean of 5.4 and 4.9 years, respectively; 426 women developed incident breast cancer. RRSO was modelled as a time-dependent covariate in Cox regression, and its effect assessed in premenopausal and postmenopausal women. RESULTS: There was no association between RRSO and breast cancer for BRCA1 (HR = 1.23; 95% CI 0.94-1.61) or BRCA2 (HR = 0.88; 95% CI 0.62-1.24) mutation carriers. For BRCA2 mutation carriers, HRs were 0.68 (95% CI 0.40-1.15) and 1.07 (95% CI 0.69-1.64) for RRSO carried out before or after age 45 years, respectively. The HR for BRCA2 mutation carriers decreased with increasing time since RRSO (HR = 0.51; 95% CI 0.26-0.99 for 5 years or longer after RRSO). Estimates for premenopausal women were similar. CONCLUSION: We found no evidence that RRSO reduces breast cancer risk for BRCA1 mutation carriers. A potentially beneficial effect for BRCA2 mutation carriers was observed, particularly after 5 years following RRSO. These results may inform counselling and management of carriers with respect to RRSO.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.189
Threshold uncertainty score0.997

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.340
Teacher spread0.324 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations74
Published2020
Admission routes2
Has abstractyes

Explore more

Same venueBreast Cancer ResearchSame topicBRCA gene mutations in cancerFrench-language works237,207